Clinical profiles and risk assessment in patients with antiphospholipid antibodies.

Authors: Kato M, Hisada R, Atsumi T Abstract INTRODUCTION: Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia associated with the presence of persistent antiphospholipid antibodies. Owing to recent studies, not only APS patients but also incidentally-identified, asymptomatic antiphospholipid antibody (aPL) carriers are able to be stratified in terms of the risk of future thrombotic events, according to the variety and the titer of positive aPL tests and to the non-thrombotic, aPL-associated clinical manifestations. Areas covered: Here, we critically review (a) criteria manifestations of APS, (b) non-criteria manifestations of APS, (c) risk assessment in patients with APS and in aPL carriers, and (d) the potential role of primary thrombosis prophylaxis in aPL ca...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2SNQvVo